Top compounds associated with response to TREH


Feature Type Standardized
Nominal ANOVA
mRNA Docetaxel gCSI pan-cancer AAC -0.2 0.0003
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0004
mRNA paclitaxel gCSI pan-cancer AAC -0.19 0.0004
mRNA Doxorubicin gCSI pan-cancer AAC -0.19 0.0005
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.14 0.0005
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0005
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0005
mRNA selumetinib:BRD-A02303741 (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA neratinib CTRPv2 pan-cancer AAC 0.14 0.0006
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.14 0.0006
Download CSV